SLG
GRTS

Stanley-Laman Group’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Stanley-Laman Group’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-28,125
Closed -$313K – 284
2019
Q2 		$313K Buy
+28,125
New +$322K 0.08% 224

Other funds holding GRTS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Stanley-Laman Group's GRTS Position: Q3 2019 in Review

Stanley-Laman Group sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2019, closing a stake of 28,125 shares — an estimated $313K sold.

Stanley-Laman Group first reported a position in GRTS in Q2 2019 and held it in 1 quarter. The position peaked at $313K in Q2 2019. 61 funds tracked by Wall St. Rank hold GRTS as of Q3 2019.

  • Stanley-Laman Group reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Stanley-Laman Group sold 28,125 Gritstone bio, Inc. Common Stock shares in Q3 2019, an estimated $313K.
  • Stanley-Laman Group first reported a position in Gritstone bio, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Stanley-Laman Group's Gritstone bio, Inc. Common Stock position peaked at $313K in Q2 2019.
  • 61 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2019.

Based on Stanley-Laman Group's 13F filing for Q3 2019, filed 8 Nov 2019.